These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21572642)

  • 21. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
    Nonn L; Peng L; Feldman D; Peehl DM
    Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
    Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
    Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.
    Kumagai T; O'Kelly J; Said JW; Koeffler HP
    J Natl Cancer Inst; 2003 Jun; 95(12):896-905. PubMed ID: 12813173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D in Prostate Cancer.
    Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
    Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
    Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
    Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.
    Taghizadeh F; Tang MJ; Tai IT
    Mol Cancer Ther; 2007 Jan; 6(1):309-17. PubMed ID: 17237289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer.
    Lopes N; Paredes J; Costa JL; Ylstra B; Schmitt F
    Breast Cancer Res; 2012 May; 14(3):211. PubMed ID: 22676419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
    Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
    Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancer survivors and vitamin D: a review.
    Hines SL; Jorn HK; Thompson KM; Larson JM
    Nutrition; 2010 Mar; 26(3):255-62. PubMed ID: 20004077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.
    Li J; Luco AL; Ochietti B; Fadhil I; Camirand A; Reinhardt TA; St-Arnaud R; Muller W; Kremer R
    Endocrinology; 2016 Jun; 157(6):2204-16. PubMed ID: 27119753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin.
    Zhu Y; Chen P; Gao Y; Ta N; Zhang Y; Cai J; Zhao Y; Liu S; Zheng J
    EBioMedicine; 2018 Apr; 30():148-157. PubMed ID: 29628342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.
    Chu B; Liu F; Li L; Ding C; Chen K; Sun Q; Shen Z; Tan Y; Tan C; Jiang Y
    Cell Death Dis; 2015 Mar; 6(3):e1686. PubMed ID: 25766325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D's role in cell proliferation and differentiation.
    Samuel S; Sitrin MD
    Nutr Rev; 2008 Oct; 66(10 Suppl 2):S116-24. PubMed ID: 18844838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C; Colston K; Dalgleish AG; Galustian C
    Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
    Berkovich L; Ben-Shabat S; Sintov AC
    Anticancer Drugs; 2010 Jul; 21(6):609-18. PubMed ID: 20335794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.